The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Familial lipoprotein disorders in patients with premature coronary artery disease.
Abstract
BACKGROUND: Genetic lipoprotein disorders have been associated with premature coronary artery disease (CAD). METHODS AND RESULTS: The prevalence of such disorders was determined in 102 kindreds (n = 603 subjects) in whom the proband had significant CAD documented by angiography before the age of 60 years. Fasting plasma cholesterol, triglyceride, low density lipoprotein (LDL) cholesterol, apolipoprotein (apo) B, and lipoprotein (a) [Lp(a)] values above the 90th percentile and high density lipoprotein (HDL) cholesterol and apo A-I below the 10th percentile of age- and sex-specific norms were defined as abnormal. An abnormality was noted in 73.5% of probands compared with 38.2% in age-matched controls (p less than 0.001), with a low HDL cholesterol level (hypoalphalipoproteinemia) being the most common abnormality (39.2% of cases). In these kindreds, 54% had a defined phenotypic familial lipoprotein or apolipoprotein disorder. The following frequencies were observed: Lp(a) excess, 18.6% (includes 12.7% with no other dyslipidemias); hypertriglyceridemia with hypoalphalipoproteinemia, 14.7%; combined hyperlipidemia, 13.7% (11.7% with and 2.0% without hypoalphalipoproteinemia); hyperapobetalipoproteinemia (elevated apo B only), 5%; hypoalphalipoproteinemia, 4%; hypercholesterolemia (elevated LDL only), 3%; hypertriglyceridemia, 1%; decreased apo A-I only, 1%. Overall, 54% of the probands had a familial dyslipidemia; unclassifiable lipid disorders (spouse also affected) were found in 3%. No identifiable familial dyslipidemia was noted in 43% of kindreds of those; nearly half (45%) had a sporadic lipid disorder. Parent-offspring and proband-spouse correlations for these biochemical variables revealed that lipoprotein and apolipoprotein levels are in part genetically determined, with Lp(a) showing the highest degree of parent-offspring correlation. CONCLUSIONS: Our data indicate that more than half of patients with premature CAD have a familial lipoprotein disorder, with Lp(a) excess, hypertriglyceridemia with hypoalphalipoproteinemia, and combined hyperlipidemia with hypoalphalipoproteinemia being the most common abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,159
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,910
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels: The Framingham Study
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.1986.03380200073024 · Cited by 1,611
Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107332 · Cited by 1,443
The mysteries of lipoprotein(a).
Utermann, G. (1989) · Science · doi:10.1126/science.2530631 · Cited by 1,257
SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN
Martin, M., Browner, W., Hulley, S., Kuller, L., & Wentworth, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90597-0 · Cited by 1,120
Dahlen, G. H., Guyton, J. R., Attar, M., Farmer, J. A., Kautz, J. A., & Gotto, A. M. (1986) · Circulation · doi:10.1161/01.cir.74.4.758 · Cited by 911
Sniderman, A., Shapiro, S., Marpole, D., Skinner, B., Teng, B., & Kwiterovich, P. O. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.604 · Cited by 633
Soria, L. F., Ludwig, E. H., Clarke, H. R., Vega, G. L., Grundy, S. M., & McCarthy, B. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.587 · Cited by 633
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
Goldstein, J. L., Hazzard, W. R., Schrott, H. G., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107331 · Cited by 622
Mohamed, S. D., & Roberts, M. (1965) · PubMed · Cited by 612
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537
Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions
McNamara, J. R., & Schaefer, E. J. (1987) · Clinica Chimica Acta · doi:10.1016/0009-8981(87)90188-4 · Cited by 521
Self-citationLp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction
MURAI, A., MIYAHARA, T., FUJIMOTO, N., MATSUDA, M., & KAMEYAMA, M. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90048-1 · Cited by 383
Rall, S. C., Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.15.4696 · Cited by 345
Genest, J., McNamara, J. R., Ordovas, J. M., Jenner, J. L., Silberman, S. R., Anderson, K. M., Wilson, P. W. F., Salem, D. N., & Schaefer, E. J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90520-w · Cited by 331
Self-citationFAMILY STUDY OF SERUM LIPIDS AND LIPOPROTEINS IN CORONARY HEART-DISEASE
Nikkilä, E., & Aro, A. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91598-5 · Cited by 292
Slack, J., & Evans, K. A. (1966) · Journal of Medical Genetics · doi:10.1136/jmg.3.4.239 · Cited by 283
Apoproteins B and A-I and coronary artery disease in humans.
Brunzell, J. D., Sniderman, A. D., Albers, J. J., & Kwiterovich, P. O. (1984) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.4.2.79 · Cited by 279
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia
CHAIT, A., ALBERS, J. J., & BRUNZELL, J. D. (1980) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1980.tb00004.x · Cited by 277
Deitch, R. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91664-0 · Cited by 249
Genetic factors affecting blood lipoproteins: the candidate gene approach.
Lusis, A. J. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38516-3 · Cited by 221
Association between a specific apo B mutation and familial defective apoB100
Soria, L. (1989) · Medical Entomology and Zoology · Cited by 212
PLASMA-TRIGLYCERIDES IN REGULATION OF H.D.L.-CHOLESTEROL LEVELS
Schaefer, E. J., Anderson, D. W., Brewer, H. B., Levy, R. I., Danner, R. N., & Blackwelder, W. C. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91863-9 · Cited by 196
Self-citationOrdovas, J. M., Cassidy, D. K., Civeira, F., Bisgaier, C. L., & Schaefer, E. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84708-7 · Cited by 183
Self-citationSchaefer, E. J. (1984) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.4.4.303 · Cited by 175
Self-citationApolipoproteins and Coronary Artery Disease
Kottke, B. A., Zinsmeister, A. R., Holmes, D. R., KNELLER, R. W., Hallaway, B. J., & Mao, S. J. T. (1986) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61947-8 · Cited by 156
Karathanasis, S. K., Ferris, E., & Haddad, I. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7198 · Cited by 151
Ordovás, J. M., Civeira, F., Genest, J. J., Craig, S., Robbins, A. H., MEADE, T., Pocoví, M., Frossard, P. M., Masharan, U., Wilson, P. W. F., et al. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90234-t · Cited by 146
Self-citationPrevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease.
Genest, J. J., McNamara, J. R., Upson, B. M., Salem, D. N., Ordovás, J. M., Schaefer, E. J., & Malinow, M. R. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1129 · Cited by 142
Self-citationInheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotype
Rose, H. G., Kranz, P., Weinstock, M., Juliano, J., & Haft, J. I. (1973) · The American Journal of Medicine · doi:10.1016/0002-9343(73)90218-0 · Cited by 132
Durrington, P. N., Hunt, L. P., Ishola, M., Kane, J. W., & Stephens, W. P. (1986) · Heart · doi:10.1136/hrt.56.3.206 · Cited by 120
Enzyme-linked immunosorbent assay for human plasma apolipoprotein B
Ordovás, J. M., Peterson, J., Santaniello, P., Cohn, J. S., Wilson, P. W. F., & Schaefer, E. J. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38611-9 · Cited by 119
Self-citationGenetic basis of lipoprotein disorders.
Breslow, J. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114176 · Cited by 105
Kissebah, A. H., Alfarsi, S., & Evans, D. J. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.6.614 · Cited by 97
DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease
GENESTJR, J., Ordovás, J. M., McNamara, J. R., Robbins, A. H., MEADE, T., COHN, S., Salem, D. N., WILSON, P., Masharani, U. B., & Frossard, P. M. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90138-9 · Cited by 95
Self-citationSerum Lipids in Angiographically Assessed Coronary Atherosclerosis
Frick, M. H., Dahlén, G. H., Berg, K., et al. (1978) · CHEST Journal · doi:10.1378/chest.73.1.62 · Cited by 95
Familial hypo-alpha-lipoproteinemia
Vergani, C., & Bettale, G. (1981) · Clinica Chimica Acta · doi:10.1016/0009-8981(81)90226-6 · Cited by 89
Primary and familial hypoalphalipoproteinemia
Third, J. L. H. C., Montag, J., Flynn, M. A., Freidel, J. F., Laskarzewski, P. M., & Glueck, C. J. (1984) · Metabolism · doi:10.1016/0026-0495(84)90126-4 · Cited by 86
Metabolism of apolipoproteins A-I, A-II, and A-IV
Schaefer, E. J., & Ordovás, J. M. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)29083-7 · Cited by 77
Self-citationMolecular basis of familial hypercholesterolemia.
Russell, D. W., Esser, V., & Hobbs, H. H. (1989) · PubMed · Cited by 76
Sane, T., & Nikkilä, E. A. (1988) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.8.3.217 · Cited by 60
Human Genetics and Coronary Heart Disease: A Public Health Perspective
Hopkins, P. N., & Williams, R. R. (1989) · Annual Review of Nutrition · doi:10.1146/annurev.nu.09.070189.001511 · Cited by 55
Causes of high blood cholesterol.
Grundy, S. M., & Vega, G. L. (1990) · Circulation · doi:10.1161/01.cir.81.2.412 · Cited by 46
Genest, J. J., Corbett, H. M., McNamara, J. R., Schaefer, M. M., Salem, D. N., & Schaefer, E. J. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90114-2 · Cited by 29
Self-citationA major gene for primary hypoalphalipoproteinemia.
Borecki, I. B., Rao, D. C., Third, J. L. H. C., et al. (1986) · PubMed · Cited by 24
Cited by
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
Self-citationWood, D., De Backer, G., Faergeman, O., Graham, I., Mancia, G., & Pyörälä, K. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)90209-x · Cited by 1,255
Second Joint Task Force of European (1998) · European Heart Journal · doi:10.1053/euhj.1998.1243 · Cited by 1,131
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887
“(119, 120) proposed that familial hypoalphalipoproteinemia (FHA), a disorder with elevated triglyceride and low HDL cholesterol, was a common genetic dyslipidemia associated with premature CVD.”
Metadata
- Authors
- Genest, J. J., Martin-Munley, S. S., McNamara, J. R., Ordovas, J. M., Jenner, J., Myers, R. H., Silberman, S. R., Wilson, P. W., Salem, D. N., & Schaefer, E. J.
- Venue
- Circulation
- Published
- 1992-06
- Volume
- 85
- Issue
- 6
- Pages
- 2025-2033
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1973178110
- Cited by
- 596
- References
- 48
- FWCI
- 18.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.